Question 1

What is the catalog number for Tislelizumab (Anti-PDCD1 / PD-1 / CD279)?

Accepted Answer

The catalog number for Tislelizumab (Anti-PDCD1 / PD-1 / CD279) is A3039-1mg*25.

Question 2

What sizes are available for Tislelizumab (Anti-PDCD1 / PD-1 / CD279)?

Accepted Answer

Tislelizumab (Anti-PDCD1 / PD-1 / CD279) is available in the following size(s): 5x 1 mg.

Question 3

Is Tislelizumab (Anti-PDCD1 / PD-1 / CD279) in stock?

Accepted Answer

Tislelizumab (Anti-PDCD1 / PD-1 / CD279) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Tislelizumab (Anti-PDCD1 / PD-1 / CD279)

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

CD20 / MS4A1 (B-Cell Marker) (MS4A1/3409), CF594 conjugate, 0.1mg/mL

HSP27 (HSPB1/774), CF640R conjugate, 0.1mg/mL

NRF1 (NRF1/2609), CF647 conjugate, 0.1mg/mL

Cytochrome p450 (M12P4H2), CF594 conjugate, 0.1mg/mL

Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2712), CF405S conjugate, 0.1mg/mL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/1887R), 1mg/mL